Clinical Trials · NCT02975297
Exenatide Once Weekly for Smoking Cessation
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- The University of Texas Health Science Center, Houston
- Enrollment
- 84
- Start date
- Jul 2016
- Locations
- 1 site, United States
- Primary endpoint
- Number of Participants Who Self-Reported Abstinence and Who Were Biochemically Verified as Abstinent Via Expired CO Level of ≤ 5ppm